Concord Wealth Partners Edwards Lifesciences Corp Transaction History
Concord Wealth Partners
- $603 Million
- Q4 2024
A detailed history of Concord Wealth Partners transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Concord Wealth Partners holds 52 shares of EW stock, worth $3,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 52
-0.0%
Holding current value
$3,768
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding EW
# of Institutions
1,384Shares Held
454MCall Options Held
6.71MPut Options Held
3.17M-
Vanguard Group Inc Valley Forge, PA69.1MShares$5.01 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.69 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.87 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY14.9MShares$1.08 Billion0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA13.6MShares$989 Million0.08% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $44.8B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...